南美超级胎牛血清999尝鲜特惠
miR-22-3p/PGC1β通过PPARγ通路抑制乳腺癌细胞肿瘤发生
miR-22-3p/PGC1β Suppresses Breast Cancer Cell Tumorigenesis via PPARγ
Xuehui Wang, Zhilu Yao, Lin Fang
Journal：PPAR Research
IF：4.96
DOI：10.1155/2021/6661828
PMID：33777130
Published：2021-03-13
research field：医学遗传学分子生物学生殖医学产前诊断
Abstract
In this study, we found that miR-22-3p expression was decreased in breast cancer (BC) cell lines and tissues. Overexpression of miR-22-3p inhibited the proliferation and migration of BC cells in vitro and in vivo, while depletion of miR-22-3p exhibited the opposite effect. Importantly, miR-22-3p could directly target PGC1β and finally regulate the PPARγ pathway in BC. In conclusion, miR-22-3p/PGC1β suppresses BC cell tumorigenesis via PPARγ, which may become a potential biomarker and therapeutic target.
本文使用的Yeasen产品
相关产品
产品应用
